Meet us at DCAT Week, the premier business development event for companies engaged in pharmaceutical development and manufacturing. Contact us today to schedule a meeting!
Noramco is a global leader in controlled substance APIs for the pharmaceutical industry, focusing on
attention deficit hyperactivity disorder (ADHD), pain management and addiction treatment and abuse prevention (ATAP). A full range of drug development support includes reference and small-scale manufacturing, process and analytical services, formulation and full regulatory filing capabilities.
DCAT Week is the premier business development event for companies engaged in pharmaceutical development and manufacturing and related industries. It is organized and hosted by the Drug, Chemical & Associated Technologies Association (DCAT), a not-for-profit, member-supported, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies.